SAN ANTONIO — A small pilot study delivered a big message about the use of testosterone in men with advanced or metastatic prostate cancer, according to a "Best Abstract" presented at the Sexual ...

A prostate cancer survivor asks about testosterone therapy risks, and another reader questions CPAP supply replacement ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

Federal regulators are moving to rewrite the rulebook on testosterone replacement therapy, easing warnings that have shaped ...

"FDA's responsibility is to ensure prescribing information reflects the best available scientific evidence." ...

The 2026 proposal is seemingly shifting the TRT landscape, moving it further from the “use with caution” territory.

First-of-its-kind study on 266 men found 20% have higher levels of the hormone in the vessels surrounding the prostate. Drawing blood from the arms of prostate cancer patients to assess for ...

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...

This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...

Men with low-risk prostate cancer and hypogonadism may safely receive testosterone therapy Testosterone saturation model suggests limited cancer growth stimulation by normal hormone levels Studies ...

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...